(Approval lapsed) Carbidopa and Levodopa Extended-release tablets 50mg/200mg (carbidopa/levodopa 50mg/200mg)
Section 19A approved medicine
(Approval lapsed) Carbidopa and Levodopa Extended-release tablets 50mg/200mg (carbidopa/levodopa 50mg/200mg)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
SINEMET CR levodopa/carbidopa 200mg/50mg modified release tablet bottle - ARTG 171694
Indication(s)
Idiopathic parkinsonism, where standard formulations containing levodopa/carbidopa have produced inadequate control. Experience is limited in patients who have not been treated with levodopa before.